Cargando…
Development of Self-Administered Formulation to Improve the Bioavailability of Leuprorelin Acetate
In recent years, the development of self-injectable formulations has attracted much attention, and the development of formulations to control pharmacokinetics, as well as drug release and migration in the skin, has become an active research area. In the present study, the development of a lipid-base...
Autores principales: | Okada, Akie, Niki, Rina, Inoue, Yutaka, Tomita, Junki, Todo, Hiroaki, Itakura, Shoko, Sugibayashi, Kenji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031317/ https://www.ncbi.nlm.nih.gov/pubmed/35456619 http://dx.doi.org/10.3390/pharmaceutics14040785 |
Ejemplares similares
-
A Lipid-Based Depot Formulation with a Novel Non-lamellar Liquid Crystal Forming Lipid
por: Okada, Akie, et al.
Publicado: (2021) -
Six-month depot formulation of leuprorelin acetate in the treatment of prostate cancer
por: Sethi, Rajni, et al.
Publicado: (2009) -
Combined Use of N-Palmitoyl-Glycine-Histidine Gel and Several Penetration Enhancers on the Skin Permeation and Concentration of Metronidazole
por: Dahlizar, Sabrina, et al.
Publicado: (2018) -
Foreign Body Granuloma Secondary to Leuprorelin Acetate
por: Lee, Bo In, et al.
Publicado: (2014) -
Usefulness of Artificial Membrane, Strat-M(®), in the Assessment of Drug Permeation from Complex Vehicles in Finite Dose Conditions
por: Arce, Florencio Jr, et al.
Publicado: (2020)